静脉输注氯胺酮时肝酶显著升高：一例报告。
Substantial Elevation of Liver Enzymes During Ketamine Infusion: A Case Report.
机构信息
From the Department of Anesthesiology, Pain Management Center, University of Virginia Health System, Charlottesville, Virginia.
出版信息
A A Pract. 2020 Jun;14(8):e01239. doi: 10.1213/XAA.0000000000001239.
Abstract
Intravenous infusion of a subanesthetic dose of ketamine has been shown to improve neuropathic pain. However, ketamine-induced liver injury can occur. Reported here are 2 cases with substantial liver enzyme elevations less than 2 days after initiation of repeat ketamine infusion at least 7 months after the last infusion. Although their liver enzymes normalized within a few weeks, it is unclear what the long-term consequences are. Furthermore, drug-induced liver injury can cause acute liver failure. Therefore, we recommend close monitoring of liver enzymes every 1 to 2 days during ketamine infusions.
摘要
静脉输注亚麻醉剂量的氯胺酮已被证明可改善神经性疼痛。然而，氯胺酮可引起肝损伤。本文报告了 2 例患者，在末次输注氯胺酮至少 7 个月后再次输注氯胺酮至少 7 个月后，在开始输注后不到 2 天，肝酶显著升高。尽管他们的肝酶在数周内恢复正常，但尚不清楚长期后果如何。此外，药物性肝损伤可导致急性肝衰竭。因此，我们建议在输注氯胺酮期间每 1 至 2 天密切监测肝酶。
相似文献
1
Substantial Elevation of Liver Enzymes During Ketamine Infusion: A Case Report.静脉输注氯胺酮时肝酶显著升高：一例报告。
A A Pract. 2020 Jun;14(8):e01239. doi: 10.1213/XAA.0000000000001239.
2
Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.亚麻醉剂量氯胺酮输注疗法：对复杂性区域疼痛综合征一种新型治疗方法的回顾性分析
Pain Med. 2004 Sep;5(3):263-75. doi: 10.1111/j.1526-4637.2004.04043.x.
3
4
A Case Report: Subanesthetic Ketamine Infusion for Treatment of Cancer-Related Pain Produces Urinary Urge Incontinence.病例报告：亚麻醉剂量氯胺酮输注治疗癌症相关疼痛导致急迫性尿失禁。
A A Case Rep. 2017 May 1;8(9):219-221. doi: 10.1213/XAA.0000000000000472.
5
Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases.氯胺酮治疗 1 型复杂性区域疼痛综合征慢性疼痛后反复用药导致的药物性肝损伤：3 例报告。
Pain. 2011 Sep;152(9):2173-2178. doi: 10.1016/j.pain.2011.03.026. Epub 2011 May 4.
6
Racemic ketamine 4.5-day infusion treatment of long-standing complex regional pain syndrome—a prospective service evaluation in five patients.消旋氯胺酮4.5天输注治疗长期复杂性区域疼痛综合征——5例患者的前瞻性服务评估
Br J Anaesth. 2015 Jul;115(1):146-7. doi: 10.1093/bja/aev183.
7
Syndrome of Inappropriate Antidiuretic Hormone Release During Ketamine Infusion in Complex Regional Syndrome Patient Receiving Intrathecal Baclofen: A Case Report.鞘内注射巴氯芬的复杂性区域疼痛综合征患者在氯胺酮输注期间抗利尿激素分泌不当综合征：一例报告
A A Pract. 2019 Nov 15;13(10):386-388. doi: 10.1213/XAA.0000000000001091.
8
Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis.门诊氯胺酮输注治疗难治性慢性疼痛综合征的疗效：一项 5 年回顾性分析。
Pain Med. 2012 Feb;13(2):263-9. doi: 10.1111/j.1526-4637.2011.01241.x. Epub 2011 Sep 21.
9
10
What is considered long-term pain relief in chronic pain management? Re: Sigtermans et al., Pain 2009;145:304-311.
Pain. 2010 May;149(2):409-410. doi: 10.1016/j.pain.2010.03.018. Epub 2010 Apr 9.
引用本文的文献
1
Ketamine Hepatotoxicity: An Underappreciated Cause of Liver Damage - Analysis by RUCAM.氯胺酮肝毒性：一个未得到充分认识的肝损伤原因——基于RUCAM的分析
J Clin Transl Hepatol. 2025 Jun 28;13(6):524-531. doi: 10.14218/JCTH.2024.00478. Epub 2025 Apr 11.
2
The Behavioral and Neuroinflammatory Impact of Ketamine in a Murine Model of Depression and Liver Damage.氯胺酮对抑郁和肝损伤小鼠模型的行为及神经炎症影响
Int J Mol Sci. 2025 Apr 10;26(8):3558. doi: 10.3390/ijms26083558.
3
A Case of Hepatotoxicity Induced by Therapeutic Ketamine Use for Sedation.一例因治疗性使用氯胺酮镇静导致肝毒性的病例。
Case Rep Crit Care. 2024 Mar 12;2024:8366034. doi: 10.1155/2024/8366034. eCollection 2024.
4
Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders.预防和管理心境障碍患者使用氯胺酮和 Esketamine 的常见不良反应。
CNS Drugs. 2021 Sep;35(9):925-934. doi: 10.1007/s40263-021-00846-5. Epub 2021 Aug 7.
5
The Effectiveness of Ketamine in Pediatric Acute Deafferentation Pain after Spinal Cord Injury.氯胺酮对小儿脊髓损伤后急性传入神经阻滞性疼痛的疗效
Case Rep Anesthesiol. 2020 Oct 19;2020:8835292. doi: 10.1155/2020/8835292. eCollection 2020.
本文引用的文献
1
Drug-Induced Liver Injury - Types and Phenotypes.
N Engl J Med. 2019 Oct 3;381(14):1395. doi: 10.1056/NEJMc1911063.
2
The Effect of Ketamine Infusion in the Treatment of Complex Regional Pain Syndrome: a Systemic Review and Meta-analysis.氯胺酮输注治疗复杂性区域疼痛综合征的效果：系统评价和荟萃分析。
Curr Pain Headache Rep. 2018 Feb 5;22(2):12. doi: 10.1007/s11916-018-0664-x.
3
Drug-induced liver injury: Diagnosing (and treating) it early.药物性肝损伤：早期诊断（及治疗）。
J Fam Pract. 2015 Oct;64(10):634-44.
4
Chronic ketamine administration impairs mitochondrial complex I in the rat liver.慢性氯胺酮给药会损害大鼠肝脏中的线粒体复合物 I。
Life Sci. 2013 Oct 6;93(12-14):464-70. doi: 10.1016/j.lfs.2013.08.001. Epub 2013 Aug 11.
5
Ketamine for chronic pain: risks and benefits.氯胺酮治疗慢性疼痛：风险与获益。
Br J Clin Pharmacol. 2014 Feb;77(2):357-67. doi: 10.1111/bcp.12094.
6
Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases.氯胺酮治疗 1 型复杂性区域疼痛综合征慢性疼痛后反复用药导致的药物性肝损伤：3 例报告。
Pain. 2011 Sep;152(9):2173-2178. doi: 10.1016/j.pain.2011.03.026. Epub 2011 May 4.
7
8
Intravenous ketamine for CRPS: Making too much of too little?
Pain. 2010 Jul;150(1):10-11. doi: 10.1016/j.pain.2010.03.014. Epub 2010 Mar 26.
9
Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study.门诊静脉注射氯胺酮治疗复杂性区域疼痛综合征：一项双盲安慰剂对照研究。
Pain. 2009 Dec 15;147(1-3):107-15. doi: 10.1016/j.pain.2009.08.015. Epub 2009 Sep 23.
10
Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1.氯胺酮对1型复杂性区域疼痛综合征患者可产生有效且持久的疼痛缓解效果。
Pain. 2009 Oct;145(3):304-311. doi: 10.1016/j.pain.2009.06.023. Epub 2009 Jul 14.
Zotero 插件